A Win For Acasti Pharma Inc.
Wed, Dec 23, 2020 at 05:30 PM
Acasti Pharma Inc. (ACST:NASDAQ) shot up at $0.43, representing a gain of 72%. The stock got featured on our News Catalysts scanner on Thu 17 Dec 20 at 03:01 AM in the 'INVESTOR UPDATE' category. From Tue 08 Dec 20, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Tue 01 Dec 20 at $0.42 with a volume of 54M+, and its share price has been moving sideways in recent weeks.
About Acasti Pharma Inc. (ACST:NASDAQ)
Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
Top 10 Gainers:
- Ocugen, Inc. (OCGN:NASDAQ), 222.9%
- Jaguar Health, Inc. (JAGX:NASDAQ), 170.34%
- XL Group Ltd (XL:NYSE), 86.02%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 78.02%
- Acasti Pharma Inc. (ACST:NASDAQ), 72%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 50.47%
- SCPS (SCPS:NASDAQ), 47.71%
- EOSE (EOSE:NASDAQ), 44.56%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 42.35%
- Bionano Genomics, Inc. (BNGO:NASDAQ), 40.4%